FSGS

Clinical trials for FSGS explained in plain language.

Never miss a new study

Get alerted when new FSGS trials appear

Sign up with your email to follow new studies for FSGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet finished but already full! 1 Completed 1

New hope for FSGS: experimental drug APL2 enters Late-Stage trial

Disease control Terminated

This study tests an experimental drug called APL2 for people with a kidney disease called FSGS. The goal is to see if APL2 can reduce protein in the urine, a sign of kidney damage. The trial has two parts: first, adults will receive APL2 openly; then, both adults and adolescents …

Matched conditions: FSGS

Phase: PHASE2, PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

FSGS

Get alerted when new FSGS trials appear

New hope for FSGS: experimental drug APL2 enters Late-Stage trial